Characterizing dosimetric uncertainties to tumour volume and organs at risk in rectal cancer

Documents similaires

• Improving outcomes for resistant rectal cancer
  par: O'Cathail, S
  Publié: (2019)
• KEAP1-NRF2 pathway as a modulator of response to radiation in rectal cancer
  par: O'Cathail, S, et autres
  Publié: (2018)
• SBRT Pelvic re-irradiation: 2cm "rind" around PTV and small bowel dosimetry of rectal recurrences
  par: O'Cathail, S, et autres
  Publié: (2019)
• Stereotactic body radiotherapy for moderately central and ultra-central oligometastatic disease: Initial outcomes
  par: Rosie Cooke, et autres
  Publié: (2020-03-01)
• Are all colorectal oligometastases equal?
  par: O'Cathail, S, et autres
  Publié: (2018)